NSNaoki Sakakibara

Naoki Sakakibara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Naoki Sakakibara has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The accuracy and characteristics of gastric cancer treatment information in the national data of the hospital-based cancer registry

    by Manami Fujishita, Naoki Sakakibara, Takahiro Higashi, Tomone Watanabe, Hiraku Kumamaru, Hiroaki Miyata

    Objective: The hospital-based cancer registry is used extensively for research to support cancer control activities by providing an overview of how cancer treatments are provided nationwide. This study aimed to shed light on the quality and characteristics of treatment data in the hospital-based cancer registry using the linked dataset on gastric cancer. Methods: Using the nationally linked data of the hospital-based cancer registry and the health services utilization data, the treatment data in the hospital-based cancer registry for patients who were newly diagnosed with gastric cancer in 2016 and 2017 and received the first course of treatment at their own institutions were examined. The agreement rates between registry data and utilization data were analyzed by stage, treatment, age, period from the date of diagnosis to the date of treatment and hospital type. Results: The sensitivity of open surgery, laparoscopic surgery and endoscopic treatment tended to decrease in advanced stages, whereas the sensitivity of chemotherapy and radiation therapy increased. Specificity was high for all treatments and stages, at ˃90%. Sensitivity by age was slightly different for chemotherapy and radiation therapy, but specificities did not differ. For all treatments, the longer the time from diagnosis to treatment implementation, the higher the coverage rate. Conclusions: The hospital-based cancer registry recorded the treatment performed appropriately. It is necessary to interpret the data from the hospital-based cancer registry whilst keeping in mind that, chemotherapy and radiation therapy are registered less frequently than surgical treatments administered.

  • Open Access

    Validation of the Japanese version of the barriers questionnaire II in cancer pain management: a cross-sectional study

    by Naoki Sakakibara, Hiroko Komatsu, Mikako Takahashi, Hideko Yamauchi, Teruo Yamauchi, Ardith Z. Doorenbos

    Background: The Barriers Questionnaire II (BQ-II) was developed to assess barriers to effective pain management. In this study, we aimed to assess the reliability and validity of the newly developed Japanese version of the BQ-II (JBQ-II). Methods: This study used a cross-sectional design. The study was conducted an ambulatory infusion center for cancer in a general hospital in Tokyo, Japan. Participants were 120 Japanese patients with cancer and 21 Japanese health professionals with experience in pain management. Cronbach’s alpha coefficient was used to calculate reliability. Test–retest reliability was assessed with Spearman’s intra-class correlation coefficient (ICC). Construct, criterion-related, and discriminant validity were assessed using information about pain management, daily life, mental health, and subjective health. Results: The Cronbach’s alpha was 0.90 for the JBQ-II, and all ICCs exceeded 0.70 (P < 0.01). Factor analysis showed the JBQ-II had a virtually identical structure to the BQ-II, and path analysis supported the JBQ-II constructs. The JBQ-II was weakly correlated with poor mental state (r = 0.36, P < 0.01). Patients’ JBQ-II scores were significantly higher than health professionals’ scores. Conclusion: The JBQ-II is a valid and reliable measure of patient-related barriers to pain management among Japanese adult patients with cancer.


  • Open Access

    QUALITY AND PERFORMANCE EVALUATION OF CONCRETE USING COAL ASH CLASSIFIED AS TYPE Ⅳ FLY ASH

    by Naoki Sakakibara, Shota Tomiduka, Yasuhiro Koda, Ichiro Iwaki

    本研究ではフライアッシュⅣ種で管理されるがⅡ種の品質規定も一部満足する未利用の石炭灰を対象に、コンクリート用混和材としてセメントの20%質量を外割り添加したコンクリートの品質・性能評価を行った。その結果、本石炭灰はセメントと細骨材を補間する粉体としてワーカビリティーを阻害せず、コンクリートの空気連行性を確保できることが確認された。この結果を踏まえ、生コンの実用化に向け、使用する石炭灰の品質範囲を提案した。さらに、実際の場所打ちPC床版への適用性の検討を行った。フレッシュ性状と硬化性状を満足し、十分な塩分浸透抵抗性とアルカリシリカ反応抵抗性を有するコンクリートが製造可能なことを示した。

  • Open Access

    Validation of the Japanese version of the Barriers Questionnaire II in cancer pain management: a cross-sectional study

    by Naoki Sakakibara, Hiroko Komatsu, Mikako Takahashi, Hideko Yamauchi, Teruo Yamauchi, Ardith Z Doorenbos

    Background: The Barriers Questionnaire II (BQ-II) was developed to assess barriers to effective pain management. In this study, we aimed to assess the reliability and validity of the newly developed Japanese version of the BQ-II (JBQ-II).Methods: This study used a cross-sectional design. The study was conducted an ambulatory infusion center for cancer in a general hospital in Tokyo, Japan. Participants were 120 Japanese patients with cancer and 21 Japanese health professionals with experience in pain management. Cronbach’s alpha coefficient was used to calculate reliability. Test–retest reliability was assessed with Spearman’s intra-class correlation coefficient (ICC). Construct, criterion-related, and discriminant validity were assessed using information about pain management, daily life, mental health, and subjective health.Results: The Cronbach’s alpha was 0.90 for the JBQ-II, and all ICCs exceeded 0.70 (P < 0.01). Factor analysis showed the JBQ-II had a virtually identical structure to the BQ-II, and path analysis supported the JBQ-II constructs. The JBQ-II was weakly correlated with poor mental state (r = 0.36, P < 0.01). Patients’ JBQ-II scores were significantly higher than health professionals’ scores.Conclusion: The JBQ-II is a valid and reliable measure of patient-related barriers to pain management among Japanese people with cancer.

  • Open Access

    Negative pain management index scores do not necessarily indicate inadequate pain management: a cross-sectional study

    by Naoki Sakakibara, Takahiro Higashi, Itsuku Yamashita, Tetsusuke Yoshimoto, Motohiro Matoba

    The Pain Management Index (PMI) is widely used in the assessment of pain management, and negative scores are traditionally considered to indicate inadequate pain management. However, it is not known whether negative PMI scores are always problematic. In this prospective observational study, we examined the data of 1156 patients with cancer and pain who were hospitalized in a cancer care hospital in Japan from July 2012 to January 2015 and compared the proportion of patients with PI across various PMI scores in this cohort. We further evaluated the predictive validity of PMI scores for PI using different cutoffs. This study aimed to examine the association between PMI scores and the proportion of patients whose pain interferes with their daily lives (i.e., pain interference [PI]). We found that lower PMI scores were generally associated with a higher percentage of patients with PI. A smaller proportion of patients with PMI scores of − 1 (567/1550, 36.6%) reported PI compared with those with PMI scores of 0 (788/1505, 52.4%). The sensitivities of PMI scores < − 1 and < 0 for predicting PI were 0.16 and 0.37 and the corresponding specificities were 0.95 and 0.71, respectively. These findings suggest that PMI scores are inversely associated with the proportion of patients with PI. However, PMI scores of − 1 do not always indicate inadequate pain management; pain management should therefore be evaluated from multiple perspectives.


  • Treatment selection for esophageal cancer: evaluation from a nationwide database

    by Yasuo Hamamoto, Naoki Sakakibara, Fumio Nagashima, Yuko Kitagawa, Takahiro Higashi

    Most elderly patients poorly tolerate the standard treatment for esophageal cancer; however, little information is available regarding the appropriateness of non-standard esophageal cancer treatments for those patients. This study aims to analyze the treatment costs and completion rates of patients undergoing a real-world treatment for esophageal cancer to elucidate the treatment selection and its quality.


  • Current status of pain control for older cancer patients in comparison to younger patients in outpatient and inpatient settings: a report from one prefectural cancer care hospital

    by Naoki Sakakibara, Higashi Takahiro, Itsuku Yamashita, Hiroki Miura, Tetsusuke Yoshimoto, Shigeaki Yoshida, Yoshiko Hayasaka, Hiroko Komatsu, Motohiro Matoba


  • Validation of the Japanese version of the Fatigue Barriers Scale (JFBS)

    by Hiroko Komatsu, Chie Watanabe, Kaori Yagasaki, Naoki Sakakibara, Seigo Nakamura

    Background: The Fatigue Barriers Scale (FBS) is an instrument to identify patient-derived barriers to fatigue management. Objective: To assess the reliability and validity of the Japanese version of the FBS (JFBS). Methods: Participants were 112 cancer patients. Reliability was determined through internal consistency using Cronbach's alpha coefficient and through test-retest reliability using Spearman's intra-class correlation coefficient (ICC). Construct, convergent, criterion-referenced, and concurrent validities were assessed. The Cancer Fatigue Scale (CFS), Patient Fatigue Knowledge Tool (PFKT), and Kessler 6-item distress scale (K6) were used for comparisons. Results: Cronbach's alpha coefficients were 0.74, 0.78, 0.72, and 0.54 for the JFBS total and for each subscale, respectively. All ICCs exceeded 0.65 (P< 0.05). The JFBS had a weak negative correlation with the PFKT and a positive correlation with the CFS. The K6 scores showed weak positive correlations with the JFBS total and fatalism subscale scores. Conclusions: The JFBS can be used to measure fatigue barriers in Japanese people with cancer.

  • Open Access

    Aortic Valve Replacement to a Patient with High Titer of Cold Agglutinin

    by Rei Kansaku, Kenji Kuwaki, Atsushi Amano, Hirotaka Inaba, Keiichi Tambara, Taira Yamamoto, Naoki Sakakibara

    A 60-year-old man was admitted to our hospital because of aortic stenosis with a peak pressure gradient of 61 mmHg, moderate aortic regurgitation, and a dilatation of the ascending aorta of 50 mm in diameter, which had grown 5 mm in 2 years. Because of severe aortic stenosis with a bicuspid valve and fast progression of the ascending aorta in size, replacements of both the aortic valve and the ascending aorta were planned. He had experienced severe acute renal failure with hemolysis because of cold agglutinin one year before the operation. The hemoglobin had decreased to 4.3 g/dL during hemolytic attack. His titer of cold agglutinin was extremely high. The titer of cold agglutinin has kept above than 1:131072 at 4 degree Celsius. It once increased to 1:524288. Both the replacement of the aortic valve and the ascending aorta under normothermic cardiopulmonary bypass using intermittent warm blood cardioplegia were completed uneventfully. He was discharged from the hospital on postoperative day 11.


  • Open Access

    Coronary Artery Bypass Grafting in Patients With Hypopituitarism

    by Tamotsu Yasuda, Michio Kawasuji, Yoshinori Ishida, Naoki Sakakibara, Susumu Fujii, Satoru Nishida, Yoh Watanabe

    Three patients with angina pectoris and hypopituitarism underwent coronary artery bypass grafting. The patients received perioperative replacement steroid and thyroid hormone therapy, and there were no complications. Careful perioperative hormonal management is necessary for patients with hypopituitarism.